Abiraterone Acetate
| CAS No. | 154229-18-2 |
|---|---|
| MDL No. | MFCD00934213 |
| MF | C26H33NO2 |
| MW | 391.50 |
| InChI Key | UVIQSJCZCSLXRZ-UBUQANBQSA-N |
| CAS No. | 154229-18-2 |
|---|---|
| MDL No. | MFCD00934213 |
| MF | C26H33NO2 |
| MW | 391.50 |
| InChI Key | UVIQSJCZCSLXRZ-UBUQANBQSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Abiraterone acetate is a sterol ester formed by the condensation of the 3-hydroxy group of abiraterone with the carboxy group of acetic acid. It functions as a prodrug that is converted in vivo to abiraterone. Used in the treatment of metastatic castrate-resistant prostate cancer. It acts as a prodrug, an antineoplastic agent, and an inhibitor of EC 1.14.99.9 (steroid 17alpha-monooxygenase). It is a sterol ester and a pyridine derivative, functionally related to abiraterone.
| CAS No. | 154229-18-2 |
|---|---|
| Product Name | Abiraterone Acetate |